Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

mutacin 1140

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Peptidesbacteriocin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Molecular mechanisms of pore formation and membrane disruption by the antimicrobial lantibiotic peptide Mutacin 1140.
The emergence of antibiotic-resistance is a major concern to global human health and identification of novel antibiotics is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2018
2018
Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection
Lantibiotics offer an untapped pipeline for the development of novel antibiotics to treat serious Gram-positive (+) infections… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2018
2018
Blueprints for the rational design of therapeutic mutacin 1140 variants
Lantibiotics represent a large untapped pipeline of attractive scaffolds for the development of novel antibiotics. Saturation… Expand
Is this relevant?
2018
2018
OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections
Lantibiotics continue to offer an untapped pipeline for the development of novel antibiotics. We report here the discovery of a… Expand
Is this relevant?
2017
2017
Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery
ABSTRACT Mutacin 1140 belongs to the epidermin group of lantibiotics. Epidermin class lantibiotics are ribosomally synthesized… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2015
2015
Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.
UNLABELLED Lantibiotics are ribosomally synthesized peptide antibiotics composed of an N-terminal leader peptide that is cleaved… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2014
2014
The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics
Lantibiotics are ribosomally synthesized peptide antibiotics composed of an N‐terminal leader peptide that promotes the core… Expand
Is this relevant?
2010
2010
Optimization of the Production of the Lantibiotic Mutacin 1140 in Minimal Media.
Mutacin 1140 is produced by Streptococcus mutans and belongs to the type A lantibiotic family. Experiments were done to optimize… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Elucidation of the antimicrobial mechanism of mutacin 1140.
Mutacin 1140 and nisin A are peptide antibiotics that belong to the lantibiotic family. N-Terminal rings A and B of nisin A and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
Structure and dynamics of the lantibiotic mutacin 1140.
Mutacin 1140 is a member of a family of ribosomally synthesized peptide bacteriocins called lantibiotics (lanthionine-containing… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE